Now accepting a limited number of new Valerian patients each quarter · River Oaks, Houston
Reserve Your Assessment
Losing weight is
the easy part now.
Losing the right weight is not.
A GLP-1 will move the number on the scale. What it will not do on its own is decide how much of that loss comes from fat and how much comes from the muscle you spend the rest of your life needing.
The medication is one component.
It is not the plan.
GLP-1 medications changed what is possible in weight management, and there is no reason to pretend otherwise. They are genuinely effective at reducing appetite and producing meaningful weight loss. What they do not do is answer the question that actually determines how you feel and function afterward — what the weight was made of.
Most Valerian patients arriving here are not new to this. Some have already been on a GLP-1 through a telehealth service and found the number moved while the mirror did not, or that the weight returned when the prescription stopped. Others watched their body composition change in their forties without changing anything they were doing.
Both situations point at the same thing. Body composition is governed by a hormonal and metabolic environment, and that environment can either be corrected or worked around. A prescription works around it. This program corrects it — with GLP-1 therapy used inside that correction where it is clinically appropriate.
Insulin & Glucose Handling
Fasting insulin, HbA1c, and glucose. Insulin resistance is frequently the mechanism underneath weight that will not move, and it is measurable rather than inferred.
Hormonal Status
Testosterone in men, estradiol and progesterone in women. Both govern where the body stores fat and how readily it holds lean tissue.
Thyroid & Cortisol
The two most commonly missed contributors. Thyroid sets metabolic rate; chronically elevated cortisol drives central fat storage and works against everything else.
Body Composition
Measured at baseline and tracked through the program — because total weight alone cannot tell you whether the program is working or quietly costing you muscle.
Four situations.
Four different answers.
The reason weight became difficult determines what the program should do about it. These are not the same problem wearing different clothes.
Men's Metabolic Health
Visceral fat that arrived without a change in habits, alongside declining testosterone and insulin sensitivity. The composition shift is usually hormonal before it is behavioural.
Men's Metabolic Health →Women's Metabolic Health
Weight and shape that changed through perimenopause while the effort stayed constant. Estradiol, progesterone, and thyroid all shape where the body stores and what it holds onto.
Women's Metabolic Health →Composition Without Weight Change
The same number on the scale, distributed differently than it used to be. Composition is measured at baseline and tracked throughout rather than inferred from total weight.
How a program is built →When Hormones Are the Cause
Where the panel points at testosterone, estradiol, or thyroid as the driver, correcting that is the intervention. Adding a medication on top of an uncorrected environment is treating the symptom.
HRT & TRT →Protecting Lean Tissue
Where the panel supports it, peptide protocols are one of the tools used to defend lean mass during a period of active loss rather than after it is gone.
Peptides →Where Inflammation Is High
Systemic inflammatory burden and insulin resistance travel together. Where the panel shows both, addressing the inflammatory side is part of the same program.
EBOO →GLP-1 medications are prescribed only where clinically indicated following physician evaluation, and are not appropriate for everyone. Eligibility, dosing, and duration are determined solely by the physician. Individual results vary.
Appetite is one lever.
It is not the only one.
What a GLP-1 Does
Mimics an incretin hormone your gut releases after eating — slowing gastric emptying and signalling fullness. It reduces intake effectively. It does not correct why storage and composition changed in the first place.
What the Hormones Do
Testosterone, estradiol, thyroid, and cortisol determine where fat is stored, how insulin behaves, and how readily lean tissue is built or defended. Left uncorrected, they set a ceiling on what any medication achieves.
What Determines Composition
Protein intake, resistance loading, and the hormonal environment together decide whether weight comes off as fat or as fat and muscle. None of the three is supplied by a prescription.
The scale cannot tell you
what you actually lost.
This is the part of the conversation most weight loss services leave out, and it is the part that matters most for anyone who intends to stay strong into their seventies.
What the Trials Report
A systematic review of six semaglutide trials covering 1,541 patients found lean mass reductions ranging from almost none to roughly 40% of total weight lost, with the larger trials showing the more notable reductions.
Meta-analysis across GLP-1 receptor agonists places lean mass at roughly a quarter of total weight lost on average.
The picture is genuinely mixed rather than uniformly bad. Because fat loss is often greater, lean mass as a proportion of body weight frequently improves — and some studies report grip strength improving over twelve months.
What that variability tells you is that the outcome is not fixed by the drug. It is influenced by what surrounds the drug.
Source: A systematic review of the effect of semaglutide on lean mass: insights from clinical trials. Findings vary considerably across trials and populations.
Why It Matters Later
Lean mass is not a cosmetic concern. It is the strongest single predictor of functional independence in later life, the primary site of glucose disposal, and a substantial share of resting metabolic rate.
Losing it during a weight loss phase means a lower metabolic floor when the phase ends — which is one mechanism behind weight returning faster than it left. It also means arriving at seventy with less reserve than you would otherwise have had.
You do not get a second chance at the muscle you were carrying at fifty. That is the whole argument for running this as a program rather than filling a prescription.
What a Program Adds That a Prescription Cannot
Composition Measured, Not Assumed
Baseline and ongoing body composition alongside the panel. If lean mass is moving in the wrong direction, that shows up while it can still be corrected.
Protein and Loading Prescribed
Adequate protein intake and structured resistance work are the two most reliable defences against lean mass loss. Both are built into the program rather than mentioned in passing.
Hormones Corrected First
Losing weight in a hormonally depleted state makes lean tissue harder to hold. Where the panel shows that, it is addressed before or alongside rather than ignored.
Coaching Between Appointments
Appetite suppression makes eating enough protein genuinely difficult. That is a practical problem, and it is solved by someone checking in rather than by willpower.
Nobody here writes a script
and waves you off.
Find the Actual Mechanism
Insulin, thyroid, cortisol, sex hormones, inflammatory markers, and body composition. Sometimes the answer is that a GLP-1 is not what you need, and that is a legitimate outcome of an assessment.
Correct the Environment
Where hormonal or thyroid status is the driver, that is addressed directly. Some Valerian patients need no medication once it is corrected. Others need both, and the medication works considerably better afterward.
Defend the Muscle Throughout
Protein targets, resistance loading, peptide support where the panel warrants it, and composition tracked rather than inferred from the scale. This runs for the duration, not as a closing suggestion.
Plan the Exit From the Start
What happens when the medication stops is a question worth answering before it starts. A corrected hormonal environment and preserved lean mass are what make holding the result plausible rather than hopeful.
The medication is the smallest part
of what makes this work.
HRT & TRT
Where the panel identifies hormonal decline as the reason composition changed, correcting it is the actual intervention. A number of Valerian patients find they need considerably less medication, or none, once this is addressed.
Explore HRT & TRT → Protecting the downsidePeptides
Where the panel supports it, peptide protocols are one of the levers used to defend lean tissue through an active loss phase — alongside protein and loading rather than instead of them.
Explore peptides → Where inflammation is the blockEBOO
Systemic inflammatory burden and insulin resistance reinforce each other. Where a panel shows both elevated, addressing the inflammatory side belongs in the same program rather than after it.
Explore EBOO → Where intake is restrictedIV Therapy
Sustained appetite suppression can make adequate micronutrient intake genuinely hard. Where the panel shows gaps, intravenous delivery is one way to close them while intake is reduced.
Explore IV therapy →Nutrition, exercise, coaching, hormone optimization, peptide support, and supplement support are assessed alongside every program here.
See how a program is built →What Valerian patients ask
before they commit.
Where they are clinically appropriate, yes. They are genuinely effective and there is no reason to be precious about that. What differs here is that the prescription is one component of a program rather than the whole offering — and that the assessment comes first. Some Valerian patients arrive expecting a GLP-1 and leave with hormonal correction instead, because that is what their panel pointed at. Others need both. That determination is the physician's job, made from your data.
Some lean mass loss is common, and the honest answer is that the amount varies considerably. A systematic review of six semaglutide trials covering 1,541 patients found reductions ranging from almost none to roughly 40% of total weight lost, with larger trials reporting the more notable figures. Meta-analysis across the drug class puts it around a quarter of total loss on average. The picture is not uniformly bad — because fat loss is usually greater, lean mass as a proportion of body weight often improves, and some studies report grip strength improving. What that variability indicates is that the outcome is influenced by what surrounds the medication: protein intake, resistance loading, and hormonal status. Those are exactly what a program supplies and a prescription does not. The review is at PubMed.
This is the question worth asking before you start rather than a year in. Weight regain after discontinuation is well documented, and the mechanism is not mysterious — appetite returns, and if lean mass was lost along the way, resting metabolic rate is lower than when you began. What changes the picture is having corrected the underlying hormonal environment and defended lean tissue throughout. Neither guarantees anything, but they are the difference between a plausible maintenance plan and hoping.
Many Valerian patients have, and it is a reasonable place to have started. What those services generally do not include is a comprehensive panel, body composition tracking, hormonal assessment, or anyone monitoring what the weight is made of. If you are currently on a protocol and want it run properly, bring what you have — your dose, your history, and any labs — and the assessment will start from there rather than from zero.
That is a common and legitimate reason to be here, and it is usually a hormonal question rather than a caloric one. The same number on the scale distributed differently — more centrally, less lean tissue — points at testosterone, estradiol, thyroid, or insulin handling. In that situation a weight loss medication is the wrong tool entirely, and your physician will say so. See HRT & TRT for where that conversation usually goes.
Slower than the marketing suggests, and that is deliberate. Rapid loss tends to come with a worse composition outcome, because lean tissue is more readily sacrificed when the deficit is aggressive. The rate here is set against what your body composition tracking shows rather than against a target date. If lean mass starts moving in the wrong direction, the plan changes.
Valere operates as a private-pay practice. Coverage for GLP-1 medications through commercial insurance varies considerably and is worth checking with your carrier separately. The program itself — the panel, physician time, body composition tracking, and coaching — is not covered, and that is what allows it to be built around what your results actually show. Payment plans and membership options are available.
GLP-1 receptor agonists and other medications referenced on this page are prescribed only where clinically indicated following physician evaluation and are not appropriate for everyone. All clinical decisions, including eligibility, dosing, and duration, rest solely with the licensed physician. Individual results vary. This page is educational and does not constitute medical advice — please consult your primary care provider.
Find out what is actually
driving it first.
Your assessment covers insulin, thyroid, cortisol, sex hormones, and body composition. Sometimes the answer is a medication. Sometimes it is not.
Reserve Your AssessmentPrivate · By appointment only · River Oaks, Houston